Let’s dig into the relative performance of Medpace (NASDAQ:MEDP) and its peers as we unravel the now-completed Q1 drug development inputs & services earnings season. Companies specializing in drug ...

Scientists have engineered bacteria to turn plastic waste into paracetamol, offering a sustainable new path for medicine and ...

Backed by Perceptive Xontogeny Venture Funds and venBio Partners, the new biotech will make genetic medicines that don’t rely ...

Nektar Therapeutics stock launched Tuesday after the biotech company hit every goal in a midstage study of its eczema ...

Explore how 3D bioprinting is reshaping biotechnology and healthcare by enabling the creation of tissues, organs, and ...

Three months after the US Sofdra launch, prescriptions have exceeded Botanix Pharmaceuticals' expectations. What are they ...

The FDA has stopped new clinical trials that export American citizens’ living cells from the U.S. to “China and other hostile ...

A Mesa biotech medical manufacturer is seeing an uptick in demand for its wound care products, leading to an expansion of its ...

Discover Danaher's impressive financial performance, low risk, and growth potential driven by strategic investments in ...

Pearland’s Lower Kirby District in the city’s northwest corner has had several life sciences companies move into the area in recent years due to its available land, specialized workforce and proximity ...